Navigating Rapid Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC: A Practical Framework for Optimal Biomarker Testing, Treatment Selection and Sequencing, and Adverse Event Management
Chair and Presenters Natasha B. Leighl, MD, MMSc, FRCPC, FASCO, Luis Paz-Ares, MD, PhD, and Joshua S...
57 slides
18
Healthcare
PeerView